Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colombe Chappey

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
AIDS (London, England)|April 18, 2003
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistanceNeil T Parkin, Colombe Chappey, Christos J Petropoulos
Journal of Virology|August 27, 2009
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistanceMadhavi Kolli, Eric Stawiski, Colombe Chappey, et al.
Nucleic Acids Research|June 25, 2004
A web-based genotyping resource for viral sequencesMikhail Rozanov, Uwe Plikat, Colombe Chappey, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitorsNeil T Parkin, Soumi Gupta, Colombe Chappey, et al.
Antiviral Therapy|May 29, 2008
Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial databaseDamian J McColl, Colombe Chappey, Neil T Parkin, et al.
Science (New York, N.Y.)|November 30, 2004
Evidence for positive epistasis in HIV-1Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary informationNeil Parkin, Colombe Chappey, Laura Maroldo, et al.
The Journal of Infectious Diseases|September 27, 2003
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolatesJeannette M Whitcomb, Neil T Parkin, Colombe Chappey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2007
Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individualsBecky Schweighardt, Yang Liu, Wei Huang, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|April 18, 2003
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistanceNeil T Parkin, Colombe Chappey, Christos J Petropoulos
Journal of Virology|August 27, 2009
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistanceMadhavi Kolli, Eric Stawiski, Colombe Chappey, et al.
Nucleic Acids Research|June 25, 2004
A web-based genotyping resource for viral sequencesMikhail Rozanov, Uwe Plikat, Colombe Chappey, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitorsNeil T Parkin, Soumi Gupta, Colombe Chappey, et al.
Antiviral Therapy|May 29, 2008
Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial databaseDamian J McColl, Colombe Chappey, Neil T Parkin, et al.
Science (New York, N.Y.)|November 30, 2004
Evidence for positive epistasis in HIV-1Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary informationNeil Parkin, Colombe Chappey, Laura Maroldo, et al.
The Journal of Infectious Diseases|September 27, 2003
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolatesJeannette M Whitcomb, Neil T Parkin, Colombe Chappey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2007
Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individualsBecky Schweighardt, Yang Liu, Wei Huang, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
Pageof 4